🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Empagliflozin/Metformin Krka 5 mg/850 mg film-coated tablets
PA1347/122/001
Empagliflozin, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Emtricitabine/Tenofovir disoproxil Krka 200 mg/245 mg film-coated tablets
EU/1/16/1151/001-004
Emtricitabine, Tenofovir disoproxil KRKA, d.d., Novo mesto
Emtricitabine/Tenofovir disoproxil Krka d.d 200 mg/245 mg film-coated tablets
EU/1/17/1182/001-004
Tenofovir disoproxil, Emtricitabine KRKA, d.d., Novo mesto
Enalapril/Lercanidipine Krka 10 mg/10 mg film-coated tablets
PA1347/029/001
Enalapril maleate, Lercanidipine KRKA, d.d., Novo mesto Marketed
Enalapril/Lercanidipine Krka 20 mg/10 mg film-coated tablets
PA1347/029/002
Enalapril maleate, Lercanidipine KRKA, d.d., Novo mesto Marketed
Enyglid 0.5 mg tablets
EU/1/09/580/1-6
Repaglinide KRKA, d.d., Novo mesto
Enyglid 1 mg tablets
EU/1/09/580/7-12
Repaglinide KRKA, d.d., Novo mesto
Enyglid 2 mg tablets
EU/1/09/580/13-18
Repaglinide KRKA, d.d., Novo mesto
Eplerenone Krka 25 mg film-coated tablets
PA1347/078/001
Eplerenone KRKA, d.d., Novo mesto Marketed
Eplerenone Krka 50 mg film-coated tablets
PA1347/078/002
Eplerenone KRKA, d.d., Novo mesto Marketed
ESCADRA 20 mg hard gastro-resistant capsules
PA1347/123/001
Esomeprazole KRKA, d.d., Novo mesto Not marketed
ESCADRA 40 mg hard gastro-resistant capsules
PA1347/123/002
Esomeprazole KRKA, d.d., Novo mesto Not marketed
Escitalopram Krka 10 mg film-coated tablets
PA1347/046/002
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 15 mg film-coated tablets
PA1347/046/003
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 20 mg film-coated tablets
PA1347/046/004
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 5 mg film-coated tablets
PA1347/046/001
Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Esomeprazole Krka 20 mg hard gastro-resistant capsules
PA1347/017/001
Esomeprazole KRKA, d.d., Novo mesto Marketed
Esomeprazole Krka 40 mg hard gastro-resistant capsules
PA1347/017/002
Esomeprazole KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 120 mg film-coated tablets
PA1347/064/004
Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 30 mg film-coated tablets
PA1347/064/001
Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 60 mg film-coated tablets
PA1347/064/002
Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 90 mg film-coated tablets
PA1347/064/003
Etoricoxib KRKA, d.d., Novo mesto Marketed
Ezetimibe Krka 10 mg tablets
PA1347/066/001
Ezetimibe KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/10 mg film-coated tablets
PA1347/116/001
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/20 mg film-coated tablets
PA1347/116/002
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/40 mg film-coated tablets
PA1347/116/003
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/80 mg film-coated tablets
PA1347/116/004
Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Simvastatin Krka 10 mg/10 mg tablets
PA1347/067/001
Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Not marketed
Ezetimibe/Simvastatin Krka 10 mg/20 mg tablets
PA1347/067/002
Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Marketed
Ezetimibe/Simvastatin Krka 10 mg/40 mg tablets
PA1347/067/003
Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Marketed
Febuxostat Krka 120 mg film-coated tablets
EU/1/18/1347/005-008
Febuxostat KRKA, d.d., Novo mesto
Febuxostat Krka 80 mg film-coated tablets
EU/1/18/1347/001-004
Febuxostat KRKA, d.d., Novo mesto
Fingolimod Krka 0.5 mg hard capsules
PA1347/101/001
FINGOLIMOD HYDROCHLORIDE KRKA, d.d., Novo mesto Marketed
Galsya SR 16 mg prolonged-release capsules, hard
PA1347/015/002
Galantamine KRKA, d.d., Novo mesto Marketed
Galsya SR 24 mg prolonged-release capsules, hard
PA1347/015/003
Galantamine KRKA, d.d., Novo mesto Marketed
Galsya SR 8 mg prolonged-release capsules, hard
PA1347/015/001
Galantamine KRKA, d.d., Novo mesto Marketed
Icorvida SR 1.5mg Prolonged-release Tablets
PA1347/022/001
Indapamide KRKA, d.d., Novo mesto Marketed
Ifirmacombi 150 mg/12.5 mg film-coated tablets
EU/1/11/673/001-008
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto
Ifirmacombi 300 mg/12.5 mg film-coated tablets
EU/1/11/673/009-016
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto
Ifirmacombi 300 mg/25 mg film-coated tablets
EU/1/11/673/017-024
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto
Ifirmasta 150 mg film-coated tablets
EU/1/08/480/7-12
Irbesartan KRKA, d.d., Novo mesto
Ifirmasta 300 mg film-coated tablets
EU/1/08/480/13-18
Irbesartan KRKA, d.d., Novo mesto
Ifirmasta 75 mg film-coated tablets
EU/1/08/480/1-6
Irbesartan KRKA, d.d., Novo mesto
Imatinib Krka d.d 100 mg film-coated tablets
PA1347/054/001
Imatinib KRKA, d.d., Novo mesto Marketed
Imatinib Krka d.d. 400 mg film-coated tablets
PA1347/054/002
Imatinib KRKA, d.d., Novo mesto Marketed
Ivabradine Krka 5 mg film-coated tablets
PA1347/065/001
Ivabradine KRKA, d.d., Novo mesto Marketed
Ivabradine Krka 7.5 mg film-coated tablets
PA1347/065/002
Ivabradine KRKA, d.d., Novo mesto Marketed
Kamiren 4 mg prolonged-release tablets
PA1347/038/001
Doxazosin KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 100 mg film-coated tablets
PA1347/099/002
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 150 mg film-coated tablets
PA1347/099/003
Lacosamide KRKA, d.d., Novo mesto Marketed
1 2 3 4 5 6

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.